Bortezomib induces schedule-dependent modulation of gemcitabine pharmacokinetics and pharmacodynamics in non-small cell lung cancer and blood mononuclear cells

C. Ceresa, E. Giovannetti, J. Voortman, A. Laan, R.J. Honeywell, G. Giaccone, G.J. Peters

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)1026-1036
JournalMolecular Cancer Therapeutics
Volume8
Issue number5
DOIs
Publication statusPublished - 2009

Cite this